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Abstract 
Background: As malaria elimination becomes a goal in malaria-endemic nations, questions of feasibility become 
critical. This article explores the potential challenges associated with this goal and future strategies for malaria elimina-
tion in the Greater Mekong Sub-region.
Methods: Thirty-two semi-structured interviews were conducted with policy makers (n = 17) and principal investiga-
tors (n = 15) selected based on their involvement in malaria prevention, control and elimination in the GMS. Inter-
views were audio-recorded and transcribed for qualitative content (thematic) analysis using QSR NVivo.
Results: All respondents described current malaria control and elimination strategies, such as case detection and 
management, prevention and strengthening of surveillance systems as critical and of equal priority. Aware of the 
emergence of multi-drug resistance in the GMS, researchers and policy makers outlined the need for additional elimi-
nation tools. As opposed to a centralized strategy, more targeted and tailored approaches to elimination were recom-
mended. These included targeting endemic areas, consideration for local epidemiology and malaria species, and 
strengthening the peripheral health system. A decline in malaria transmission could lead to complacency amongst 
funders and policy makers resulting in a reduction or discontinuation of support for malaria elimination. Strong com-
mitment of policymakers combined with strict monitoring and supervision by funders were considered pivotal to 
successful elimination programmes.
Conclusion: Against a backdrop of increasing anti-malarial resistance and decreasing choices of anti-malarial regi-
mens, policy makers and researchers stressed the urgency of finding new malaria elimination strategies. There was 
consensus that multi-pronged strategies and approaches are needed, that no single potential tool/strategy can be 
appropriate to all settings. Hence there is a need to customize malaria control and elimination strategies based on the 
better surveillance data.
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Background
The burden of malaria in the Greater Mekong Sub‑region
In line with global trends, the Greater Mekong Sub-
region (GMS) has recently recorded declines in 
malaria-related mortality and morbidity, which reflect a 
substantial reduction in transmission [1–4]. The recent 
emergence of artemisinin resistance in the region could 
however reverse these gains [5, 6]. Scientists are con-
cerned about the potential spread of artemisinin-resist-
ant Plasmodium falciparum parasites to Africa, where 
this would likely result in a major public health crisis [7]. 
With the apparent decrease in regional malaria preva-
lence and the need to contain the spread of resistance, 
researchers have redoubled efforts and adapted strategies 
to eliminate malaria from the GMS [8, 9].
Challenges of malaria elimination in the Greater Mekong 
Sub‑region
Efforts to contain the spread of artemisinin-resistant 
malaria must overcome several challenges [10]. In the 
GMS, malaria transmission now mostly occurs in remote 
locations, such as forest fringes and forested areas, and 
among populations who live and depend on the for-
est, including- migrant workers and subsistence farmers 
[11]. Access to these areas to deliver malaria control and 
prevention programmes is therefore difficult. Additional 
challenges include the increasing resistance to insecti-
cides, including pyrethroids and DDTs [12], and the wide 
circulation of substandard and counterfeit antimalarials 
in the region [13–15].
Health systems are often weak in the region, with limi-
tations in terms of implementing proven interventions, 
poor governance, corruption and weak supply chain 
logistics [16, 17]. Malaria case detection and treatment 
depends on the peripheral health system and village 
malaria workers (VMWs) or village health volunteers 
[18–20]. Village malaria workers diagnose malaria and 
provide treatment to community members, in addition 
to maintaining malaria surveillance data [18, 20]. Irregu-
lar funding for VMWs and inadequate opportunities for 
their skill development and training have had a negative 
impact on treatment and the quality of surveillance data 
[21].
Current malaria elimination strategies in the Greater 
Mekong Sub‑region
Multi-pronged approaches are necessary to tackle 
these challenges and several elimination strategies have 
recently been piloted. For example, targeted malaria 
elimination (TME), which includes mass drug admin-
istration (MDA), the distribution of insecticide-treated 
bed nets (ITNs), strengthening of village networks of 
health workers, has been assessed in Cambodia, Lao 
PDR, Myanmar and Vietnam [8, 22–29]. The recent 
scale-up of TME along the Thai–Myanmar border, which 
included strengthened, diagnosis and treatment with 
additional malaria posts established within the villages, 
has illustrated how timely access to treatment, together 
with targeted MDA, can help reduce the incidence of P. 
falciparum to zero [9]. These findings suggest that elimi-
nation in the GMS could become a reality [30].
Malaria elimination as a goal in the Greater Mekong 
Sub‑region
Nations within the GMS have adopted the goal of elimi-
nating all forms of malaria by 2030 [31] (see Table 1 for 
details) [32, 33]. The World Health Organization’s Global 
Technical Strategy 2016–2030 (GTS) identifies three 
essential pillars that underpin strategies for malaria elim-
ination [33]: (1) ensuring universal access to malaria pre-
vention, diagnosis and treatment; (2) accelerating efforts 
towards elimination and attainment of malaria free sta-
tus; and, (3) transforming malaria surveillance into a 
core intervention. The pillars can be tailored to national 
and sub-national settings to increase the effectiveness of 
elimination programmes [33]. The GTS together with the 
WHO’s Action and Investment to Defeat Malaria 2016–
2030 (AIM) lay out a detailed pathway to elimination.
Aim
Adopting the goal of elimination by 2030 without exam-
ining potential barriers may lead to wasted resources 
and may ultimately contribute to failure. Policy mak-
ers and leading malariologists can offer insights into the 
practicalities of elimination, which have seen insufficient 
attention. Drawing on semi-structured interviews, this 
article explores the perspectives of stakeholders working 
in malaria elimination at the policy level (governmen-
tal and non-governmental) and research, with a view to 
addressing the following research questions:
1. What do researchers, policy makers and funders per-
ceive to be major barriers, in terms of practicality and 
feasibility, to achieving malaria elimination in the 
GMS?
2. What do they perceive as plausible strategies to over-
come such barriers?
Methods
Data were collected as part of the qualitative study, 
“Stakeholder perspectives on mass drug administra-
tion and malaria elimination in the Greater Mekong 
Sub-region”.
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Respondents
Respondents were recruited based on their expertise 
(principal investigators of current malaria elimination 
studies and senior malariologists) or decision-making 
roles in malaria prevention, control and elimination in 
the GMS (policy makers in Thailand, Cambodia, Myan-
mar, Vietnam or Laos, and funders, such as from the 
World Health Organization and the Bill and Melinda 
Gates Foundation). Potential respondents were identified 
through a combination of (1) a snowball approach, and 
(2) bibliography and web searches. The appropriateness 
of potential respondents, identified during interviews or 
web searches, was discussed among core members of the 
research team.
The contact details of potential respondents were 
obtained from institutional websites or from other 
respondents. Potential respondents were subsequently 
contacted by email. None of the potential respondents 
explicitly refused to participate. Two potential partici-
pants could not be reached for the interview.
The recruitment of respondents was based on purpose-
ful sampling and recruitment continued until theoretical 
saturation (whereby newly collected information does 
not provide additional insights) [34, 35]. To include maxi-
mum diversity of opinion among respondents, respond-
ents from the field of malaria research and policy were 
approached who were recognized as endorsing different 
approaches to malaria elimination in the GMS.
Study tool
A topic guide for the semi-structured interviews was 
developed in consultation with members of the study 
team, drawing on the initial research questions. Top-
ics included malaria elimination, MDA and community 
engagement. Under these broad topics, a flexible and 
iterative approach was taken to questioning to elicit in-
depth information and to ensure that relevant topics 
were not neglected. This study aimed to explore perspec-
tives of researchers, policy makers and funders concern-
ing the practicality and feasibility including challenges of 
achieving malaria elimination in the GMS without spe-
cific focus on species of malaria.
Data collection
Data collection was conducted between October 2016 
and April 2017 at various locations in Thailand, Myan-
mar, Cambodia, Laos, Vietnam and the USA. Whenever 
possible, interviews were conducted face-to-face at a 
study site of a pilot malaria elimination strategy, selected 
international tropical medicine conferences or at the 
ministerial offices. If a face-to-face meeting was not pos-
sible, Skype or telephone interviews were conducted. 
Two respondents were not available for a face-to-face or 
a telephone/Skype-interview but responded to an email 
questionnaire.
Interviewers were conducted by the first author, a med-
ical doctor, with master’s in tropical medicine and pub-
lic health, training in qualitative and quantitative social 
science research methods. Data collection (and analy-
sis) was supervised by an experienced qualitative social 
scientist (last author). All interviews were conducted 
in English and ranged from 20 to 90  min in length. On 
average, interviews with policy makers and funders were 
longer than those with scientists. Interviews were audio-
recorded and transcribed verbatim by an independent 
transcriber and, using the recordings, the interviewer 
checked all transcripts for accuracy.
Data analysis
The interview transcripts were analysed using qualita-
tive data analysis software (NVivo 11; QRS International, 
Australia). A codebook adapted from previous qualita-
tive research on TME and community engagement (in 
Cambodia, Laos and Myanmar) was used [26]. Line-by-
line coding of transcripts used pre-established themes 
(deductive approach), e.g., malaria elimination, com-
munity engagement, and MDA, followed by themes that 
emerged during the data analysis (inductive approach). 
Analysis continued by identifying and explaining promi-
nent themes and patterns amongst respondents and out-
liers. For coding reliability, all coding was initially done 
independently by three researchers (NK, BA and CP) and 
then compared and discussed. Any disagreement among 
the researchers was resolved by discussions and only the 
agreed on codes were finally presented.
Ethics approval
Initial data collection was conducted as part of the ethics 
approval for the TME project [8, 26] that included ethical 
approval from each countries and are as follows:
Cambodia: National Ethics Committee for Health 
Research Cambodia (NECHR 0042 & 0051) and the 
Oxford Tropical Research Ethics Committee (OXTREC; 
1017–13); Laos: Lao National Ethics Committee for 
Health Research (Ref. No. 013-2015/NECHR), Govern-
ment of the Lao PDR and the Oxford Tropical Research 
Ethics Committee (1015–13); Vietnam: the Institute 
of Malariology, Parasitology and Entomology in Ho 
Chi Minh City (185/HDDD), the Institute of Malariol-
ogy, Parasitology and Entomology in Qui Nhon and the 
Oxford Tropical Research Ethics Committee (1015-13); 
Myanmar: ethics Review Committee of the Department 
of Medical Research (Ref: 74/Ethics 2014) and the Oxford 
Tropical Research Ethics Committee (23–15; 1015–13), 
the Tak Province Community Ethics Advisory Board and 
the village committees.
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Subsequently, further Ethical approval was obtained 
from the Oxford Tropical Research Ethics Commit-
tee (OxTREC) and was approved on 31 January, 2017 
(Unique Protocol ID: OxTREC ref: 5122-16). Verbal 
informed consent was obtained from all respondents 
prior to interviews. Interviewees were given an expla-
nation about the study, its rationale and the volun-
tary nature of their participation. All respondents were 
briefed that they could drop out of the study at any time 
during the interview without providing justification. 
Anonymity and confidentiality were secured for all the 
interviewees.
Results
Between October 2016 and April 2017, a total of 32 
semi-structured interviews (SSIs) were conducted with 
17 policy makers and 15 leading malariologists. None of 
the respondents explicitly refused to participate but two 
were not responsive to repeated e-mails. Policy makers 
included three women and 14 men; researchers included 
three woman and 12 men.
Guided by the research questions, the findings are pre-
sented by the themes that emerged during the interviews, 
integrating responses from policy makers and research-
ers. The themes included: (1) tools for malaria elimina-
tion; (2) feasibility of malaria elimination; and, (3) future 
strategies for malaria elimination.
Tools for malaria elimination
Most of the broad strategies for malaria elimination 
described by policy makers reflected national malaria 
policies. Interventions, such as detecting and treating 
malaria cases as well as the importance of a strong sur-
veillance system, were highlighted by most researchers.
“Actually, we’re focusing on five main pillars: malaria 
prevention, vector control, case management, detect-
ing and treating the cases, and improving the surveil-
lance system” (SSI with a policy maker #3).
Village malaria workers
Drawing on the recent experience in the Thai–Myanmar 
border region, researchers particularly supported the 
establishment of malaria posts to support elimination. 
However, several respondents were skeptical about the 
sustainability of health workers in the villages.
“[…] Now that we have the data, we know that the 
malaria posts are pretty easy, scalability-wise, and 
they have a huge impact [on malaria incidence].” 
(SSI with a senior researcher #26)
“Everybody likes talking about community health 
workers, village health workers. Give me one place 
where government has scaled this up and main-
tained it over a long period of time while making 
sure that these people are supervised, trained, sup-
plied so that they get regular supplies.” (SSI with a 
policy maker #14)
Insecticide‑treated bed nets
Several researchers questioned the benefits of bed nets 
for malaria control in the GMS. They highlighted the 
biting habits of the highly diverse vectors in the region, 
including Anopheles maculatus, Anopheles minimus, 
Anopheles dirus, which generally bite outdoors and 
before dusk. This contrasts with sub-Saharan Africa, 
where the principal vectors, specifically Anopheles gam-
biae, bite indoors and at night. Several researchers 
described bed nets as insufficient to prevent human-vec-
tor contact in the GMS and as a waste of money.
“We confirmed that bed nets are utterly useless. We 
confirmed that. We proved it. Nobody wants to listen 
to this because bed net is a dogma. You have to have 
a bed net. If you don’t have a bed net; if you don’t 
distribute bed nets to people, you are a criminal. 
They are utterly useless and they are expensive.” (SSI 
with a senior researcher #27)
“Bed nets work in most places but don’t work well 
in the Southeast Asian region because, again, of the 
behaviour of the vector and the early evening bit-
ing patterns and also the behavior of the humans.”  
(SSI with a senior researcher #31).
Meanwhile, most policy makers in the GMS reported 
that bed nets are a suitable and important tool for 
malaria control.
“We are using the current tools, like bed nets and 
hammocks for preventing malaria, and also repellent”  
(SSI with a senior policy maker #3)
Case detection and management
Most researchers agreed on the importance of effective 
case-detection and management systems and highlighted 
especially the establishment and expansion of well-func-
tioning health and/or malaria posts in affected areas.
“But just as the logistics rolled out and everything, it 
dawned on us that the malaria posts were going to 
be more and more important. And now that we have 
the data, we know that the malaria posts are pretty 
easy, scalability-wise, and they have a huge impact 
“(SSI with a senior researcher #26).
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Mass drug administration
MDA was mentioned by some researchers and they 
were aware of its potential benefits, especially in high 
transmission areas. A few researchers described MDA 
as playing an important role in elimination in general; 
most considered it to have an adjunctive function to 
accelerate the process within a package of interven-
tions. All respondents considered relying solely on 
MDA questionable. Researchers identified specific 
challenges related to MDA, its implementation, and the 
need to achieve high coverage, especially with several 
intervention rounds. The logistics of MDA were also 
considered expensive.
“First of all, MDA cannot lead to elimination. It 
is now recognized that MDA must be part of the 
package—if you want to—for elimination. This 
would be part of good malaria case management 
and vector control as to give good case manage-
ment, good diagnosis, good treatment and even-
tually distribute nets or hammocks, if it’s useful.”  
(SSI with a senior policy maker #5).
“Now on the specific question of MDA, I would say 
two things. First is that it’s not the most important 
tool for malaria elimination by far; with that drug 
and that schedule and under those circumstances, 
it’s not the most important tool of elimination but 
it helps. What it does is that it accelerates elimina-
tion. You will eliminate malaria without doing it, no 
doubt about it. We have done it in refugee camps in 
Thai villages, we can. It just takes longer. just takes 
longer.” (SSI with a senior researcher #27).
Vaccination
Several researchers mentioned the potential role of 
vaccinations, but none of the interviewees was aware of 
a malaria vaccine that could be used on a large scale. 
In addition, many showed concern regarding ‘safety and 
efficacy’ of currently available or tested vaccines.
“So I mean, if we had a vaccine that was safe and 
effective and deployable, affordable, and protected 
people for a year, that’d be great, and maybe we 
have got one already, and we need to evaluate it, 
but for me, in this region, we just have to rely on 
those drugs, and we’re losing those drugs.” (SSI with 
a senior researcher #31).
Challenges of malaria elimination
Among the policy makers, a few suggested large-scale 
elimination interventions when proposing possible 
future malaria elimination strategies, referring to suc-
cessful interventions in China and Sri Lanka,
“The operational feasibility—is more complicated 
and is where I argue don’t try to contain in small 
pockets; try to eliminate the whole region through 
regionally coordinated efforts.” (SSI with a policy 
maker #14)
Policy makers also pointed out significant challenges of 
implementation: most favoured targeting malaria in par-
ticular endemic areas with high-risk populations, such as 
mobile migrants and forest goers.
“The next step for malaria elimination is we have to 
work hard, we have to intervene in various affected 
areas. We cannot neglect the wild areas… In this 
country, we try to focus on where the problem is.” 
(SSI with a policy maker #9)
Funding
Researchers and policy makers mentioned the impor-
tance of continuous funding to reach the goal of elimi-
nating malaria. Several respondents highlighted the 
important role of the Bill & Melinda Gates Foundation 
and the Wellcome Trust. Significant concerns regarding 
future funding were highlighted by several government 
representatives, warning that malaria elimination may 
fail without continuous financial support.
“But still we need more money. If we had the money 
we also can invest with our guidelines to implement 
our strategic activity.” (SSI with a policy maker #4)
Among the researchers there was skepticism about 
whether funding was a big problem.
“What if there is too much money with too little gov-
ernance. If we really wanted to eliminate malaria, 
it would be rather expensive. It depends on how fast 
you want to go. But to go fast would be—I mean, to 
do mass drug administration on an extensive scale 
in the Greater Mekong sub Region would cost a lot of 
money, no doubt. But what happens at the moment 
because the governance is so weak, and the donors 
are so irresponsible about the money they provide.” 
(SSI with a senior researcher # 31)
Some described how funding has led to significant cor-
ruption in the system, which may threaten elimination 
efforts and consequently lead to further spread of resist-
ant malaria.
“There is too much money. Now in Southeast Asia 
for eliminating malaria, there is too much money. 
That creates corruption. Corruption is going to kill it 
because the work will not be done, malaria will not 
be eliminated and it will come back, resistant this 
time. There is too much money so people are corrupt 
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and there’s corruption everywhere. When malaria 
comes back; not only will there not be more money 
probably, but it will be too late.” (SSI with a senior 
researcher #27).
Some researchers blamed many policy makers’ poor 
knowledge of malaria as a threat to achieving elimina-
tion. They pointed out that several strategies, based on 
unfounded assumptions, had been implemented and 
failed to have a positive impact but consumed a lot of 
money.
“The big corruption is in the brain, it is that if peo-
ple are convinced- and there are honest people in the 
Ministries. They are honest. They are not corrupt. 
But if they think that they can utilize this money all 
the way up here without spending money here, I call 
it corruption, corruption of the mind. That corrup-
tion of the mind is not only at the Ministry of Health, 
it’s all the way to the WHO. The WHO thinks that 
if you distribute bed nets to these people, you are 
going to eliminate malaria. That’s corrupted because 
it’s wrong thinking. It’s the corruption of the system. 
Your operating system is corrupted. Your computer 
is corrupted. You have corrupted files in your oper-
ating system and that’s a problem. You have to delete 
those files. As long as you don’t do that, it doesn’t 
work.” (SSI with a senior researcher #27).
Some suggested that spending money on inefficient 
strategies results in a decreased budget for necessary 
future interventions. Other researchers described how the 
irresponsibility of donors and inadequate supervision of 
funding leads to ‘a disconnect’ between the different lev-
els of programme administration, from the donor down 
to the interventions in the field. Researchers described the 
acceptance of dishonesty and corruption as critical factors 
that might undermine malaria elimination efforts. Other 
respondents viewed the ineffectiveness of programmes as 
intentional and a way of maintaining funding streams.
“Inefficiency is a nice word. Corruption is a nasty 
word. They merge beautifully into each other.” (SSI 
with a senior researcher #31).
Researchers emphasized the importance of lasting and 
effective surveillance system, which is difficult to sustain 
with just volunteer workers.
“I think what will happen is they [the governmental 
institutions] will rely on volunteers and that it will 
work for a period of time, and then after a while, 
people will get paid jobs, and so they move away or 
something falls apart. And it doesn’t end up work-
ing.” (SSI with a senior researcher #26).
Future strategies for malaria elimination
Researchers and policy makers were generally optimistic 
about the possibility of eliminating malaria and referred 
to the recent commitment and endorsement by most 
GMS countries and the WHO. However, some research-
ers expressed concern that, due to the heterogeneity of 
malaria, individual strategies will have to be tailored to 
cope with the diversity of the region, and that includes 
local epidemiology, species, geographic situation, acces-
sibility, willingness and support of the local population to 
accept the particular intervention.
“The feasibility right now if you allow me to refer to 
Laos. One of the main challenges for elimination is 
capacity to de-strategize and to target interventions 
that are more efficient and more applicable for elim-
ination but it’s not only because of the capacity of the 
country but also because there is different—it’s quite 
a heterogeneous situation of malaria in the country 
in the south with transmission of malaria both vivax 
and falciparum.” (SSI with a policy maker #1).
Referring to political commitment, researchers and 
policy makers pointed out the danger of a central-
ized strategy of malaria elimination, which may fail due 
to a lack of expertise and ignorance of the situation in 
endemic areas, which could threaten the success of elimi-
nation. Understanding and engaging with communities 
where transmission is ongoing was emphasized as an 
important strategy.
“The way they monitor now and operate, that is a 
very centralized power in one person or in the whole 
effort. In the capital, one person makes promises and 
the person decides 100% by himself who to hire. To 
me it’s not very efficient way of working. Especially 
when you have to work at community, at grass root-
level, and also because at all the levels of the health 
system people have no information or have not been 
trained on elimination.” (SSI with a policy maker #1).
Some researchers mentioned that although it may be 
possible to eliminate P. falciparum, the challenge of com-
pletely eliminating malaria depends on addressing vivax 
malaria.
“If we get to real elimination, particularly in Asia 
and Latin America, we have got to kill vivax.” (SSI 
with a senior researcher #20).
The elimination of all malaria species was considered 
possible by some researchers, but requires recognizing 
the importance of intense vector control, community 
engagement and MDA.
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“Then [in] 2000 we report[ed] it: malaria eradica-
tion is possible on islands by existing tools that are 
there. MDA and sustained vector control with [a] 
high degree of community engagement.” (SSI with a 
senior researcher #21).
In addition to strengthening the existing case detection 
and management programmes at village level, research-
ers described targeting large communities with multiple 
strategies as critical to accelerate malaria elimination. 
There were clear differences between researchers and 
policy makers regarding approaches to halt the spread 
of artemisinin combination therapy resistance from the 
region. Policy makers emphasized the importance of a 
well-functioning primary health care system, whereas 
researchers focused on the acceleration of malaria elimi-
nation by using more intensive approaches such as MDA 
and mass screening and treatment, with a focus on spe-
cific populations, such as forest goers and migrants.
Discussion
Overall findings
Policy makers and researchers agreed regarding the 
urgency of malaria elimination against the backdrop 
of increasing anti-malarial resistance (in the GMS). 
Researchers and policy makers expressed concern over 
the currently available tools for malaria elimination, 
challenges related to implementation and future strate-
gies. Although policy makers and researchers agreed 
that there was a need to strengthen case detection and 
treatment programmes, opinions differed in their assess-
ment of the efficacy of the available elimination tools 
and strategies. Researchers and policy makers agreed on 
the absence of and the need for an omnipotent tool, e.g., 
vaccine that provides complete, life-long protection and 
could be used globally. They also recommended a tailored 
approach targeting primarily malaria endemic settings or 
pockets of malaria in combination with intense commu-
nity engagement and collaborative efforts to strengthen 
the peripheral health systems [29, 36, 37].
Tools
Among the various tools for malaria elimination, there 
was an explicit divergence of opinions on the use and 
efficacy of bed nets between policy makers and research-
ers. In contrast to policy makers, researchers thought 
bed nets in Southeast Asia provide little or no protection 
against malaria as opposed to sub-Saharan Africa where 
long-lasting, insecticide-treated bed nets play a leading 
role in malaria prevention. In Southeast Asia, because 
the main malaria vectors, such as Anopheles minimus, 
Anopheles maculatus and Anopheles dirus, feed outdoors 
during the day, specifically between 6 and 7 p.m. i.e., not 
when people are in bed [38, 39]. The continued distribu-
tion of bed nets may be driven by policy makers’ desire 
to conform with WHO guidelines for malaria vector con-
trol, which outline tools including ITNs and IRS together 
with supplementary interventions [40] and may be seen 
to provide something apparently useful to their constitu-
encies even if bed nets, for example, offer little protection 
in the GMS.
Both researchers and policy makers highlighted the 
importance of strengthening village malaria workers 
and peripheral health systems. Recent evidence from a 
TME scale-up project along the Thai–Myanmar border 
showed that establishing and relying on village malaria 
worker network at malaria posts is critical for malaria 
elimination [9].
Although researchers and policy makers described the 
need for more effective tools for rapid elimination, opin-
ions on the benefit of MDA were mixed [10]. MDA was 
seen as challenging because of the resources required, 
the emerging resistance against artemisinin or its part-
ner drugs coupled with presumption that MDA could 
accelerate resistance [7]. However, a recent pilot study 
of MDA for malaria elimination in the GMS has shown 
that MDA was safe and could be used as a potential strat-
egy to expedite malaria elimination as part of a package 
of interventions [8, 9, 41]. A potential vaccine against 
malaria was discussed by several researchers but none 
knew of an available vaccine which could be used on a 
large scale in the near future [42]. The feasibility of imple-
menting successfully these tools is however dependent by 
the regional context where a number of challenges have 
been identified.
Feasibility and challenges of malaria elimination
Researchers and policy makers explained that the region’s 
geography presents barriers and facilitating factors for 
malaria elimination [43, 44]. Highlighting the successful 
elimination of malaria from island nations, such as Tai-
wan, Vanuatu and Sri Lanka, respondents emphasized 
that malaria elimination from islands are likely to be 
more promising than in landlocked areas where malaria 
is more easily re-introduced [36, 43–46]. Research-
ers viewed peripheral health facilities as inadequately 
resourced for the populations they are supposed to serve 
in the GMS.
Researchers saw vivax malaria as a further challenge 
of malaria elimination [47]. In contrast to falciparum, 
vivax is difficult to eliminate due to the liver stages (hyp-
nozoites) of the parasite, which can remain dormant for 
months to years and therefore interfere with efforts to 
interrupt transmission [48, 49]. In recent years, there has 
been a proportionate surge in prevalence of P. vivax infec-
tions in South East Asia [29, 48, 50–52]. For instance, in 
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Laos, prevalence of vivax was 11.1% compared to 3.6% 
falciparum among a total of 888 asymptomatic persons 
in 2016 [50]. To achieve the goal of malaria elimination 
in the GMS, respondents recommended including vivax 
elimination as an additional consideration when devel-
oping future strategies [53, 54]. Treating vivax malaria 
entails providing radical therapy using 8-aminoquilonoes 
such as Primaquine for 14  days [55]. Primaquine how-
ever has a haemolytic effect in G6PD deficient patients 
and therefore a routine test for G6PD deficiency before 
providing treatment is essential, which adds an additional 
layer of challenges [53, 56].
Respondents did not specifically express concern about 
counterfeit antimalarials in the GMS (and their poten-
tial impact). Many have however called for the need to 
strengthen regional and local pharmacovigilance mecha-
nisms to reduce the danger of further accelerating anti-
malarial resistance [33, 57, 58]. Considering its global 
and regional prevalence, concerted efforts of WHO, 
regional and national regulatory systems are essential to 
tackle counterfeit and sub-standard antimalarials [57]. 
Although ACTs are often freely provided at peripheral 
health centres, in some remote and malaria endemic 
regions within the GMS, the lack of health facilities, 
meant that patients seek treatment from illegal drug 
vendors and consequently receive counterfeit or sub-
standard medication [28, 59]. This emphasizes need to 
strengthen and sustain the peripheral health workforce in 
the GMS.
Funding
Securing continued funding in the face of a declining 
malaria burden was identified as a major challenge by 
many policy makers [60–62]. As malaria declines glob-
ally, researchers were worried about an increasing com-
placency that may overlook the need and importance 
for continuity in malaria control and elimination pro-
grammes [33]. Some researchers were skeptical about 
the actual decline of malaria, mostly because some of the 
data available from the national malaria reports were not 
completely representative of the current epidemiology 
and did not reflect the resurgence of malaria in specific 
geographic regions. This further reflects the need for a 
robust surveillance data for an appropriate and tailored 
response. Researchers were also critical of the utilization 
(and misuse) of funding allocated for nations embarking 
on malaria elimination, referring to systemic corruption 
[63, 64]. According to other researchers, an allocated 
amount of funding was misused for ineffective interven-
tions, such as the distribution of bed nets in the GMS 
[38]. Some researchers described how excessive funding 
without adequate supervision and monitoring by funding 
agencies has fostered more corruption.
Challenges associated with funding are also often inter-
twined in the political environment of the country. Con-
ducive political environment is indispensable for research 
projects to operate [10]. Political opposition at any level 
can affect the research projects to generate new evidence 
for the development of potential elimination strategies 
[10, 65]. A recent study showed that a lack of knowledge 
and misconceptions of malaria amongst policy makers 
has delayed implementation of MDA pilot studies in the 
GMS [10]. In the future, collaborations between policy 
makers and researchers are essential in exploring the 
regions’ strategies for malaria elimination.
Future strategies
In the GMS, future strategies for malaria elimination 
require the tailoring of those laid out in the GTS for 
global malaria elimination, which includes [33]:
1. Ensuring universal access to malaria prevention, 
diagnosis and treatment A critical and foremost 
step would be to strengthen the peripheral health 
system by sustaining the network of VMWs who 
are at the frontline of health services in villages [21, 
66]. Strengthening these networks by establishing 
malaria posts for diagnosis and treatment, which 
can expedite the access to remote and underserved 
populations [9]. In addition, a recent study has high-
lighted that collaborating with formal and informal 
health care providers in remote locations can further 
increase accessibility [28].
2. Accelerating efforts towards elimination and attaining 
malaria-free status Recent advances in malaria elimi-
nation strategies, such as MDA in the GMS have 
provided mixed results [8, 24, 41, 67]. Nevertheless, 
a combination of MDA together with a strengthen-
ing of the networks of village malaria workers, with 
the addition of malaria posts and preventive strate-
gies has shown promising results and can be scaled 
up to accelerate malaria elimination [9]. In the GMS, 
as malaria is receding to geographically inaccessible 
areas, forest-goers and migrant and mobile popula-
tions, increased efforts towards these special areas 
and populations are indispensable to attain malaria 
elimination [11].
3. Transforming malaria surveillance and response into 
a core intervention Strengthening existing surveil-
lance and response through collaboration with the 
health system and stakeholders should be a prior-
ity. Because malaria endemic regions in the GMS 
are often remote and inaccessible, surveillance 
and response heavily relies on the functioning of 
the peripheral health system [18] as well as the vil-
lage malaria networks. Integrating surveillance and 
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response into the health system, and its peripheral 
health structures, is impeded by weak governance, 
corruption and lack of qualified human resources. 
In light of these challenges, more health system- and 
operational research is critical to explore feasibility. 
Surveillance and response (diagnosis and treatment) 
through establishing malaria posts has shown prom-
ising results along the Thai–Myanmar border [9], 
however, its uptake by the health system and imple-
mentation at regional level are yet to be evaluated.
In addition, ongoing research in vaccine development 
[68], new long-lasting organophosphorous insecticides 
for indoor residual spraying [69], long-lasting insecticide 
treated bed nets (mostly for Africa) [70], new generation 
ACTs (or newer combinations) [71], high quality and 
affordable rapid diagnostic tests (RDTs) [72, 73] as well 
as the use of technologies such as mobile phones, global 
positioning system (GPS) and internet may able to opti-
mise future interventions [73, 74].
Strengths and limitations
Using a snowball approach to recruit participants facili-
tated access to difficult-to-reach policy makers involved 
in malaria prevention and control in the GMS as well as 
to key decision-makers and large international funders. 
Although such an approach has the potential to bias 
the composition of respondents, efforts were made to 
include experts from the field of malaria control and 
elimination who were recognized to have an influence 
in current and future malaria elimination strategies. 
Interviews that could not possible face-to-face were con-
ducted via Skype/telephone or in two cases via e-mail 
(questionnaire). The information collected during these 
interviews may have been affected by the limited inter-
action between the interviewer and the interviewee, nev-
ertheless, in all cases, the responses addressed the main 
research topics. Although not ideal, this approach pro-
vided useful information that otherwise would not have 
been included.
Conclusions
Against a backdrop of increasing anti-malarial resist-
ance and decreasing choices of anti-malarial regimens, 
policy makers and researchers stressed the urgency 
of finding new malaria elimination strategies. There 
was consensus that multi-pronged strategies and 
approaches are needed, that no single potential tool/
strategy can be appropriate to all settings. Hence there 
is a need to customize malaria control and elimination 
strategies based on the better surveillance data.
Among policy makers, misunderstandings and inad-
equate knowledge of malaria transmission dynamics 
in the region contribute to support for sub-optimal 
interventions, delays the development of new and badly 
needed elimination strategies, and results in the misal-
location of funds needed for other approaches. Closer 
collaboration between policy makers and researchers 
may help to overcome some of these barriers.
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Fund and the budget for malaria elimination 
in the Greater Mekong Sub-region
Country Received 
to date
Regular 
GF 
allocation 
(2014–
2017)a
RAI 
(2014–
2016)b
Total 
(2014–
2017)
New 
allocation 
2018–
2020
Cambodia $120 M 
(2003–)
$30 M $15 M $45 M $43.0 M
Lao PDR $54 M 
(2003–)
$12.5 M $5 M $17.5 M $13.3 M
Myanmar $60 M 
(2005–)
$26 M $40 M $66 M $96.1 M
Thailand $59 M 
(2004–)
$35 M $10 M $45 M $23.3 M
Viet Nam $50 M 
(2004–)
$7 M $15 M $22 M $32.6 M
RAI inter-
country
$15 M $15 M $34.0 M
Total 
(US$)
$343 M $110.5 M $100 M $210.5 M $242.3 M
Source: Global Fund
a
 Global Fund
b
 Regional artemisinin-resistance Initiative
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